Literature DB >> 20392471

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.

Kabamba B Alexandre1, Elin S Gray, Bronwen E Lambson, Penny L Moore, Isaac A Choge, Koleka Mlisana, Salim S Abdool Karim, James McMahon, Barry O'Keefe, Rachel Chikwamba, Lynn Morris.   

Abstract

Griffithsin (GRFT), Cyanovirin-N (CV-N) and Scytovirin (SVN) are lectins that inhibit HIV-1 infection by binding to multiple mannose-rich glycans on the HIV-1 envelope glycoproteins (Env). Here we show that these lectins neutralize subtype C primary virus isolates in addition to Env-pseudotyped viruses obtained from plasma and cervical vaginal lavages. Among 15 subtype C pseudoviruses, the median IC(50) values were 0.4, 1.8 and 20.1nM for GRFT, CV-N and SVN, respectively, similar to what was found for subtype B and A. Analysis of Env sequences suggested that concomitant lack of glycans at positions 234 and 295 resulted in natural resistance to these compounds, which was confirmed by site-directed mutagenesis. Furthermore, the binding sites for these lectins overlapped that of the 2G12 monoclonal antibody epitope, which is generally absent on subtype C Env. This data support further research on these lectins as potential microbicides in the context of HIV-1 subtype C infection. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392471      PMCID: PMC3401642          DOI: 10.1016/j.virol.2010.03.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.

Authors:  Laura G Barrientos; John M Louis; Istvan Botos; Toshiyuki Mori; Zhaozhong Han; Barry R O'Keefe; Michael R Boyd; Alexander Wlodawer; Angela M Gronenborn
Journal:  Structure       Date:  2002-05       Impact factor: 5.006

2.  A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.

Authors:  Heidi R Bokesch; Barry R O'Keefe; Tawnya C McKee; Lewis K Pannell; Gregory M L Patterson; Roberta S Gardella; Raymond C Sowder; Jim Turpin; Karen Watson; Robert W Buckheit; Michael R Boyd
Journal:  Biochemistry       Date:  2003-03-11       Impact factor: 3.162

Review 3.  Microbicides and other topical strategies to prevent vaginal transmission of HIV.

Authors:  Michael M Lederman; Robin E Offord; Oliver Hartley
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

4.  Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.

Authors:  Barry R O'Keefe; Fakhrieh Vojdani; Viviana Buffa; Robin J Shattock; David C Montefiori; James Bakke; Jon Mirsalis; Anna-Lisa d'Andrea; Steven D Hume; Barry Bratcher; Carrie J Saucedo; James B McMahon; Gregory P Pogue; Kenneth E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

5.  HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus.

Authors:  E Michelle Long; Stephanie M J Rainwater; Ludo Lavreys; Kishorchandra Mandaliya; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-20       Impact factor: 2.205

6.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

7.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

Authors:  Rogier W Sanders; Miro Venturi; Linnea Schiffner; Roopa Kalyanaraman; Hermann Katinger; Kenneth O Lloyd; Peter D Kwong; John P Moore
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.

Authors:  Che-Chung Tsai; Peter Emau; Yonghou Jiang; Baoping Tian; William R Morton; Kirk R Gustafson; Michael R Boyd
Journal:  AIDS Res Hum Retroviruses       Date:  2003-07       Impact factor: 2.205

10.  Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.

Authors:  Daniel A Calarese; Christopher N Scanlan; Michael B Zwick; Songpon Deechongkit; Yusuke Mimura; Renate Kunert; Ping Zhu; Mark R Wormald; Robyn L Stanfield; Kenneth H Roux; Jeffery W Kelly; Pauline M Rudd; Raymond A Dwek; Hermann Katinger; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

View more
  49 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

2.  The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.

Authors:  Jie Xue; Bart Hoorelbeke; Ioannis Kagiampakis; Borries Demeler; Jan Balzarini; Patricia J Liwang
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

3.  The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.

Authors:  Jie Xue; Yongguang Gao; Bart Hoorelbeke; Ioannis Kagiampakis; Bo Zhao; Borries Demeler; Jan Balzarini; Patricia J Liwang
Journal:  Mol Pharm       Date:  2012-08-21       Impact factor: 4.939

4.  UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.

Authors:  Hazel T Mufhandu; Elin S Gray; Maphuti C Madiga; Nancy Tumba; Kabamba B Alexandre; Thandeka Khoza; Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris; Makobetsa Khati
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.

Authors:  Jacklyn Johnson; Manuel G Flores; John Rosa; Changze Han; Alicia M Salvi; Kris A DeMali; Jennifer R Jagnow; Amy Sparks; Hillel Haim
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

6.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.

Authors:  Kabamba B Alexandre; Elin S Gray; Hazel Mufhandu; James B McMahon; Ereck Chakauya; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2011-12-29       Impact factor: 3.616

7.  Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.

Authors:  Kathryn Fischer; Kimberly Nguyen; Patricia J LiWang
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

8.  Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

Authors:  Kabamba B Alexandre; Penny L Moore; Molati Nonyane; Elin S Gray; Nthabeleng Ranchobe; Ereck Chakauya; James B McMahon; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2013-08-15       Impact factor: 3.616

9.  Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.

Authors:  Stig M R Jensen; Francis W Ruscetti; Alan Rein; Daniel C Bertolette; Carrie J Saucedo; Barry R O'Keefe; Kathryn S Jones
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

10.  Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.

Authors:  Briana Nixon; Martha Stefanidou; Pedro M M Mesquita; Esra Fakioglu; Theodore Segarra; Lisa Rohan; William Halford; Kenneth E Palmer; Betsy C Herold
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.